Stock Price
240.10
Daily Change
1.70 0.71%
Monthly
-39.53%
Yearly
-62.65%
Q1 Forecast
285.47

Novo Nordisk reported DKK194.05B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Bausch Health Companies USD -554M 910M Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Novo Nordisk DKK 26.56B 111.98B Jun/2025
Pacira USD 727.21M 30.55M Sep/2025
Sanofi EUR 71.71B 1.55B Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025